The sensitivity of ram erythrocyte-specific B-cells to cyclophosphane was studied. An antigen and two polyclonal activators, lipopolysaccharide and dextran sulfate, were used as the clone activators. The immunodepressant effect of cyclophosphane was found to depend on the degree of the immunocompetent clone activation. The maximal elimination of the clone under the influence of cyclophosphane occurred after its activation by the antigen and lipopolysaccharide. The drug exerted the minimal effect on the "resting" clone. The degree of suppression of the clone activated by dextran sulfate took the intermediate position.

Download full-text PDF

Source

Publication Analysis

Top Keywords

dextran sulfate
8
clone
5
[immunotropic activity
4
activity cyclophosphane]
4
cyclophosphane] sensitivity
4
sensitivity ram
4
ram erythrocyte-specific
4
erythrocyte-specific b-cells
4
b-cells cyclophosphane
4
cyclophosphane studied
4

Similar Publications

Background/objectives: Inflammatory bowel disease (IBD) is a chronic condition influenced by a variety of factors, including genetics, the environment, and gut microbiota. The incidence of IBD is increasing globally. Previous studies have shown that interactions between diet and gut microbiota influence the pathogenesis and treatment of IBD.

View Article and Find Full Text PDF

Background/objectives: The extracellular calcium-sensing receptor (CaSR) is a multifunctional receptor proposed as a possible drug target for inflammatory bowel disease. We showed previously that CaSR inhibition with NPS 2143, a negative allosteric modulator of the CaSR, somewhat ameliorated the symptoms of chemically induced severe colitis in mice. However, it was unclear whether the potential of CaSR inhibition to reduce colitis may have been overshadowed by the severity of the induced inflammation in our previous study.

View Article and Find Full Text PDF

Ulcerative colitis is a chronic relapsing-remitting and potentially progressive form of inflammatory bowel disease in which there is extensive inflammation and mucosal damage in the colon and rectum as a result of an abnormal immune response. MV130 is a mucosal-trained immunity-based vaccine used to prevent respiratory tract infections in various clinical settings. Additionally, MV130 may induce innate immune cells that acquire anti-inflammatory properties and promote tolerance, which could have important implications for chronic inflammatory diseases such as ulcerative colitis.

View Article and Find Full Text PDF

Inflammatory bowel disease (IBD) is a chronic, relapsing inflammation disorder of the gastrointestinal tract characterized by disrupted intestinal epithelial barrier function. Despite advances in treatment, including biological agents, achieving sustained remission remains challenging for many patients with IBD. This highlights the urgent need for novel therapeutic strategies.

View Article and Find Full Text PDF

Inflammatory bowel disease (IBD), including relapsing-remitting ulcerative colitis and Crohn's disease, is a non-specific chronic intestinal inflammatory disease. , which is rich in polyphenolic compounds, has been shown to exert antioxidative and anti-inflammatory effects. The research evaluates the dietary impacts of pomace, its polyphenol-rich extract, and fiber-rich residue on colitis symptoms.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!